402 related articles for article (PubMed ID: 3841229)
1. [Thyroid antibodies and their diagnostic value].
Schneidinger P; Joller-Jemelka H; Grob PJ
Schweiz Med Wochenschr; 1985 Nov; 115(44):1536-44. PubMed ID: 3841229
[TBL] [Abstract][Full Text] [Related]
2. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of thyroid antibodies].
Toldy E; Lócsei Z; Kalmár I; Varga L; Kovács LG
Orv Hetil; 1996 Sep; 137(38):2075-80. PubMed ID: 8966023
[TBL] [Abstract][Full Text] [Related]
5. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].
Rink T; Dembowski W; Schroth HJ; Klinger K
Nuklearmedizin; 2000 Aug; 39(5):133-8. PubMed ID: 10984889
[TBL] [Abstract][Full Text] [Related]
6. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A
Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
8. Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies.
Valente WA; Vitti P; Rotella CM; Vaughan MM; Aloj SM; Grollman EF; Ambesi-Impiombato FS; Kohn LD
N Engl J Med; 1983 Oct; 309(17):1028-34. PubMed ID: 6137770
[TBL] [Abstract][Full Text] [Related]
9. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
10. Thyroid autoimmunity and thyroid autonomy.
Vitti P; Mariotti S; Marcocci C; Chiovato L; Giachetti M; Fenzi G; Pinchera A
Acta Med Austriaca; 1990; 17 Suppl 1():90-2. PubMed ID: 2202187
[TBL] [Abstract][Full Text] [Related]
11. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
[TBL] [Abstract][Full Text] [Related]
12. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
13. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
14. Foetal and neonatal thyroid disorders.
Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
[TBL] [Abstract][Full Text] [Related]
15. Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.
Hovens GC; Heemstra KA; Buiting AM; Stokkel MP; Karperien M; Ballieux BE; Pereira AM; Romijn JA; Smit JW
Nucl Med Commun; 2007 Feb; 28(2):123-7. PubMed ID: 17198353
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis.
Wägar G; Mäkinen T; Lamberg BA; Gordin A; Apter L; Pekonen F
Ann Clin Res; 1982 Apr; 14(2):83-9. PubMed ID: 6184007
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
Hopf U; Fiek T; Grün R; Zuschneid W
J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
19. [Pregnancy and the thyroid gland].
Lieutaud H
Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
[TBL] [Abstract][Full Text] [Related]
20. Increased serum neopterin levels in patients with Graves' disease.
Wagner R; Hayatghebi S; Rosenkranz M; Reinwein D
Exp Clin Endocrinol; 1993; 101(4):249-54. PubMed ID: 8307114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
